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The ex utero intrapartum treatment (EXIT) procedure is a very rare technique performed in cases of fetal congenital 
malformations. The EXIT procedure increases the rate of survival at delivery by maintaining the uteroplacental 
circulation until the airway of the fetus is secured. To maintain the uteroplacental circulation, a higher dose of 
inhalational anesthetics and/or intravenous nitroglycerin can be used as compared to conventional Cesarean 
section. The aim of this report is to share our anesthetic experience during the EXIT procedure with members 
of the Korean society of anesthesiology for the first time, and to highlight the maternal implications of the use of 
inhalational anesthetics and nitroglycerin during Cesarean section for the EXIT procedure. (Korean J Anesthesiol 
2010; 59: S154-S157)
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    The ex utero intrapartum treatment (EXIT) procedure is 
an uncommon technique that is implemented to increase 
the rate of fetal survival at delivery of fetuses with congenital 
life-threatening airway obstructions such as lingual cysts [1], 
teratomas [2,3], skeletal dysplasia and micrognathia [4], and 
cystic hygromas, thyroid goiters, and neuroblastomas [5]. 
    The EXIT procedure is conducted in conjunction with an 
elective Cesarean section. The fetus is only delivered partially 
from the uterus with maintenance of the uteroplacental 
circulation. The maintained uteroplacental circulation 
permits diagnostic and/or therapeutic intervention to 
secure the fetal airway by means of direct laryngoscopy, 
fiberoptic bronchoscopy, or tracheostomy. Prerequisites for 
a successful outcome after the EXIT procedure are complete 
relaxation of the uterine muscles, maintenance of uterine 
volume, and uteroplacental circulation [5]. To maintain the 
uteroplacental circulation, high-dose inhalational anesthetics 
and/or intravenous nitroglycerin can be used, in contrast to 
conventional Cesarean section.
    The aim of this report is to share our anesthetic experience 
of the EXIT procedure for the first time with Korean journal of 
anesthesiology and to highlight the maternal implications of the 
use of inhalational anesthetics and nitroglycerin during general 
anesthesia for standard Cesarean section.S155 www.ekja.org
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    The patient was a healthy 29-year-old multigravida. In week 
28, the fetus was found to have an anterior neck mass and 
polyhydramnios was also detected by prenatal ultrasound. 
During the last four weeks prior to delivery, the neck mass grew 
substantially, had a broad base, and was 7 cm in diameter. 
An EXIT procedure was performed at week 38 of gestation 
by a multidisciplinary team of experts including a pediatric 
otorhinolaryngologist, neonatologist, obstetrician, two anesthe-
siologists, and nurses. The patient was placed in a supine 
position with a left lateral tilt to avoid aortocaval compression. 
An arterial line for continuous arterial pressure monitoring and 
two peripheral intravenous lines (16-gauge) were placed before 
induction. Endotracheal intubation (6.5 cuffed) was done after 
thiopental sodium (3 mg/kg) and succinylcholine (1.5 mg/
kg) administration by a rapid sequence induction. General 
anesthesia was maintained with sevoflurane 2-3 vol% and 
nitrous oxide in oxygen (50-50) combined with an additional 
dose of remifentanil (0.1-0.5 μg/min/kg) and rocuronium (50 
mg in total). An end-tidal (ET) concentration of sevoflurane was 
maintained at 1-1.5 minimum alveolar concentration (MAC) for 
proper uterine relaxation until the umbilical cord was clamped. 
Prior to uterine incision, the patient was given two boluses of 
intravenous nitroglycerine (30 μg), followed by an infusion at 
0.5-1 μg/kg/min to ensure uterine relaxation. To maintain 
a maternal systolic blood pressure of 100-120 mmHg, the 
following treatments were required: four boluses of intravenous 
phenylephrine (50 μg), followed by an infusion at 0.05-0.1 μg/
kg/min, an infusion of dopamine at 5 μg/kg/min, and rapid 
infusion of volume expander (500 ml). The skin incision to 
uterotomy required 22 min. At the time of uterine incision, the 
obstetrician confirmed that the uterus was fully relaxed and 
inserted an angiocatheter (20-gauge) into the uterus under the 
guidance of ultrasound for decompression by slow reduction 
of the amniotic fluid volume. A uterine incision stapling device 
was used to reduce intraoperative maternal blood loss. Then, 
the fetal head and the part of the torso just above the nipple 
were partially delivered. A sterile pulse oxymetry was applied 
at the left ear lobe of the fetus after removal of amniotic fluid, 
but reliable readings could not be obtained. Ultrasound-guided 
monitoring was done by an obstetrician for the early detection 
of placental detachment until the fetal airway was secured. The 
fetus was intubated with a 2.5 endotracheal tube by a pediatric 
anesthesiologist at the second attempt (Fig. 1). In the first 
attempt, the stylet of the endotracheal tube was not removed by 
an assistant due to the slipperiness of the vernix caseosa. The 
position of the endotracheal tube was confirmed by a sterile 
end-tidal CO2 monitor. Once the fetal airway was established 
and the positive-pressure ventilation was satisfactory, the 
umbilical cord was severed and the neonate was fully delivered 
from the uterus. Additional resuscitative efforts for the neonate 
were not required. The time between uterine incision to cord 
clamp was about 7 min. The 1-min Apgar score of the neonate 
was 7; the 5-min score was 9. After delivery, the infusions 
of nitroglycerine, dopamine, and phenylephrine were all 
discontinued, and the ET concentration of sevoflurane was 
also lowered to 0.8-1.0 vol%. Then, five units of oxytocin were 
injected intravenously by bolus, and 20 units/L was infused 
continuously. There were no bleeding problems after delivery 
of the neonate. The total operation time was 1 h 55 min. The 
estimated blood loss was 1,100 ml. The total intake of fluid 
during the operation was 1,800 ml. Both mother and neonate 
tolerated the EXIT procedure well. Three days later, the neck 
Fig. 1. Management of a potentially difficult neonatal airway on 
placental support during the ex utero intrapartum treatment 
(EXIT) procedure. Laryngoscopy and endotracheal intubation were 
performed on the partially delivered fetus.
Fig. 2. The mass excised from the neonate, which was diagnosed as a 
benign teratoma.S156 www.ekja.org
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mass of the neonate was completely excised by a pediatric 
otorhinolaryngologist. The excised mass was confirmed to be a 
5 × 5 × 5 cm benign teratoma (Fig. 2). 
Discussion
    The aim of the EXIT procedure is to manage life-threatening 
neonatal emergencies and thereby increase the survival 
rate at delivery. The EXIT procedure therefore requires a 
multidisciplinary team approach, including at least two 
anesthesiologists for both the mother and the fetus, a pediatric 
otorhinolaryngologist, an obstetric surgeon, a neonatologist, 
and a team of nurses [5].
    During the EXIT procedure, anesthesiologists have to 
maintain the uteroplacental circulation during Cesarean 
section to increase the time available to secure a potentially 
obstructed fetal airway. In conventional Cesarean section, the 
major goals are to minimize the time from anesthetic induction 
to umbilical cord clamping, thereby minimizing fetal exposure 
to inhalational anesthetics. This minimizes newborn depression 
and maternal hemorrhage. In contrast, fetal depression is not 
a consideration during the EXIT procedure. In fact, during the 
EXIT procedure, even intramuscular administration of drug 
cocktails and/or inhalational anesthetics (1-1.5 MAC) are 
recommended to ensure a motionless, well-anesthetized fetus 
[6]. Furthermore, there is no need to limit the time of anesthesia 
induction or the skin incision to delivery time.
    The anesthetic goals and principles for an EXIT procedure 
differ markedly from those for a conventional Cesarean section 
with respect to maintaining the uteroplacental circulation until 
the time of secured delivery. First, deep inhalational anesthetics 
(1.5-3 MAC) are often used to relax the uterine muscles and 
to maintain the uteroplacental circulation [7]. Inhalational 
anesthetic concentrations of at least 2 MAC are usually 
recommended for proper relaxation of the uterine muscles and 
to prevent early placenta detachment [6,8]. For rapid onset and 
offset of tocolytic action during the EXIT procedure, sevoflurane 
or desflurane are recommended. Second, tocolytic intravenous 
drugs can also be used directly during the EXIT procedure. 
These drugs include nitroglycerine and magnesium sulfate. 
However, nitroglycerin is a better choice than magnesium 
sulfate because nitroglycerin is easily titratable and short acting. 
The onset of uterine relaxation using nitroglycerin is 30-60 s, 
and a loading bolus of 100 μg with continuous dosing of 0.5-
1 μg/kg/min is recommended, as needed, to maintain effective 
uterine relaxation [9,10]. Lastly, dopamine (5 μg/kg/min), 
phenylephrine (0.05-0.1 μg/kg/min), and ephedrine bolus (5-
10 mg) can be utilized to maintain the maternal hemodynamics 
[11,12]. Many of the suggested anesthetic maneuvers used 
during the EXIT procedure to enhance uterine relaxation, such 
as the use of higher MAC inhalational anesthetics combined 
with short acting tocolytics, potentially decrease maternal blood 
pressure and uteroplacental perfusion before delivery, and may 
lead to uterine atony and continued hemorrhage post-delivery 
[13]. Meticulous on- and off-techniques are critical to achieve 
full relaxation of the uterus before delivery and to ensure proper 
contraction to prevent uterine atony and massive hemorrhage 
post-delivery.
    Diverse anesthetic methods can be used during the EXIT pro-
cedure. In our case, sevoflurane (1-1.5 MAC) and remifentanil 
(0.1-0.5 μg/kg/min) were used to maintain anesthesia. The 
ET concentration of sevoflurane was less than 2 MAC before 
the uterine incision, even though the concentration was set 
from the beginning of anesthetic induction. In addition, 30 
μg nitroglycerine was given to the patient. Palpation by the 
obstetrician surgeon confirmed that the uterine relaxation was 
still insufficient. Therefore, an additional bolus of nitroglycerine 
(30 μg) was given and infused continuously at 0.5-1 μg/kg/min. 
The uteroplacental circulation was maintained for 7 min (from 
uterine incision to cord clamping) without maternal or fetal 
accident until the fetus was intubated and the endotracheal 
tube was confirmed to be in the correct position. Usually, during 
the EXIT procedure, the dose of nitroglycerine used in the 
combined spinal epidural anesthesia is more than 100 μg in a 
bolus [10], and the ET concentration of inhalational anesthetics 
used in general anesthesia is above 2 MAC [11,12,14,15]. In our 
case, we performed general anesthesia using a lower bolus dose 
(two consecutive doses of 30 μg) of nitroglycerine and a lower 
ET concentration of inhalational anesthetics (1-1.5 MAC) to 
maintain maternal hemodynamic stability and ensure fetal 
airway safety.
    The EXIT procedure is a relatively new procedure and holds 
promise for newborns with airway obstruction. Anesthesia 
for the EXIT procedure can be performed in various ways, 
as long as uterine relaxation and uteroplacental circulation 
are maintained until the fetal airway is secured. Preoperative 
planning and communication with regard to anesthesia are the 
most important factors for success. 
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